Ho C

No ORCID on file · 1 paper in corpus
2024
Current oncology (Toronto, Ont.) ·doi:10.3390/curroncol31060260

Immune-mediated diarrhea represents a serious complication of checkpoint inhibitor therapy, especially following ipilimumab-based treatment. Efficient diagnosis and control of diarrhea remains an ongoing challenge. We developed an accelerat…